Elezanumab
Elezanumab is a fully human monoclonal antibody developed by AbbVie against repulsive guidance molecule A (RGMa). It has been tested in people with multiple sclerosis and acute ischemic stroke.
Source: Wikipedia
Text is available under the Creative Commons Attribution-ShareAlike License; additional terms may apply.